为研究不同干燥方式对低盐腌制鲍鱼复水品质的影响,本研究采用真空冷冻干燥、冷风干燥与热风干燥对其进行干燥处理,研究其复水过程的质量体积和复水率,并通过低场核磁共振(low field nuclear magnetic resonance,LF-NMR)和磁共振成像(ma...为研究不同干燥方式对低盐腌制鲍鱼复水品质的影响,本研究采用真空冷冻干燥、冷风干燥与热风干燥对其进行干燥处理,研究其复水过程的质量体积和复水率,并通过低场核磁共振(low field nuclear magnetic resonance,LF-NMR)和磁共振成像(magnetic resonance imaging,MRI)研究复水过程的水分分布以及复水后的色差、质构、组织形态、游离氨基酸等变化情况。结果表明,在72 h时真空冷冻干鲍的复水率为278.73%,显著高于冷风干鲍和热风干鲍的复水率(P<0.05)。由LF-NMR和MRI结果分析得出,不易流动水和自由水含量是三种干鲍水分含量增加的主要因素。真空冷冻干鲍、冷风干燥和热风干鲍分别在72、48和24 h时复水完成。不同的干燥方式影响复水后的质构,结果显示,三种干燥方式的鲍鱼样品硬度与咀嚼性均有显著差异(P<0.05),真空冷冻干燥鲍鱼复水后硬度和咀嚼性最低,分别为954.01和708.59 g;热风干燥鲍鱼复水后硬度与咀嚼性最高,分别为1230.14和920.02 g。组织学染色与扫描电镜结果显示,真空冷冻干鲍的肌肉组织为较疏松的多孔结构;冷风干鲍和热风干鲍的组织为较细长和致密的结构。综上,真空冷冻干燥鲍鱼的复水率最高,硬度和咀嚼性最低,口感最好,但滋味不及热风干燥鲍鱼。本研究结果可为了解不同干燥方法对低盐腌制鲍鱼产品品质的影响提供理论参考。展开更多
BACKGROUND Enterotoxins produce diarrhea through direct epithelial action and indirectly by activating the enteric nervous system.Calcium-sensing receptor(CaSR)inhibits both actions.The latter has been well documented...BACKGROUND Enterotoxins produce diarrhea through direct epithelial action and indirectly by activating the enteric nervous system.Calcium-sensing receptor(CaSR)inhibits both actions.The latter has been well documented in vitro but not in vivo.The hypothesis to be tested was that activating CaSR inhibits diarrhea in vivo.AIM To determine whether CaSR agonists ameliorate secretory diarrhea evoked by cholera toxin(CTX)in mice.METHODS CTX was given orally to C57BL/6 mice to induce diarrhea.Calcium and calci-mimetic R568 were used to activate CaSR.To maximize their local intestinal actions,calcium was administered luminally via oral rehydration solution(ORS),whereas R568 was applied serosally using an intraperitoneal route.To verify that their actions resulted from the intestine,effects were also examined on Cre-lox intestine-specific CaSR knockouts.Diarrhea outcome was measured biochemically by monitoring changes in fecal Cl-or clinically by assessing stool consistency and weight loss.RESULTS CTX induced secretory diarrhea,as evidenced by increases in fecal Cl-,stool consistency,and weight loss following CTX exposure,but did not alter CaSR,neither in content nor in function.Accordingly,calcium and R568 were each able to ameliorate diarrhea when applied to diseased intestines.Intestinal CaSR involvement is suggested by gene knockout experiments where the anti-diarrheal actions of R568 were lost in intestinal epithelial CaSR knockouts(villinCre/Casrflox/flox)and neuronal CaSR knockouts(nestinCre/Casrflox/flox).CONCLUSION Treatment of acute secretory diarrheas remains a global challenge.Despite advances in diarrhea research,few have been made in the realm of diarrhea therapeutics.ORS therapy has remained the standard of care,although it does not halt the losses of intestinal fluid and ions caused by pathogens.There is no cost-effective therapeutic for diarrhea.This and other studies suggest that adding calcium to ORS or using calcimimetics to activate intestinal CaSR might represent a novel approach for treating secretory diarrheal diseases.展开更多
基金Supported by Eunice Kennedy Shriver National Institute of Child Health&Human Development of the National Institutes of Health,No.1K08HD079674-01 and 1R41HD092133-01National Institute of Allergy and Infectious Diseases,No.1A21AI169282and VA Research Career Scientist Award,No.1IK6BX004835.
文摘BACKGROUND Enterotoxins produce diarrhea through direct epithelial action and indirectly by activating the enteric nervous system.Calcium-sensing receptor(CaSR)inhibits both actions.The latter has been well documented in vitro but not in vivo.The hypothesis to be tested was that activating CaSR inhibits diarrhea in vivo.AIM To determine whether CaSR agonists ameliorate secretory diarrhea evoked by cholera toxin(CTX)in mice.METHODS CTX was given orally to C57BL/6 mice to induce diarrhea.Calcium and calci-mimetic R568 were used to activate CaSR.To maximize their local intestinal actions,calcium was administered luminally via oral rehydration solution(ORS),whereas R568 was applied serosally using an intraperitoneal route.To verify that their actions resulted from the intestine,effects were also examined on Cre-lox intestine-specific CaSR knockouts.Diarrhea outcome was measured biochemically by monitoring changes in fecal Cl-or clinically by assessing stool consistency and weight loss.RESULTS CTX induced secretory diarrhea,as evidenced by increases in fecal Cl-,stool consistency,and weight loss following CTX exposure,but did not alter CaSR,neither in content nor in function.Accordingly,calcium and R568 were each able to ameliorate diarrhea when applied to diseased intestines.Intestinal CaSR involvement is suggested by gene knockout experiments where the anti-diarrheal actions of R568 were lost in intestinal epithelial CaSR knockouts(villinCre/Casrflox/flox)and neuronal CaSR knockouts(nestinCre/Casrflox/flox).CONCLUSION Treatment of acute secretory diarrheas remains a global challenge.Despite advances in diarrhea research,few have been made in the realm of diarrhea therapeutics.ORS therapy has remained the standard of care,although it does not halt the losses of intestinal fluid and ions caused by pathogens.There is no cost-effective therapeutic for diarrhea.This and other studies suggest that adding calcium to ORS or using calcimimetics to activate intestinal CaSR might represent a novel approach for treating secretory diarrheal diseases.
